Cargando…
Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats
Aim: In China, warfarin is usually prescribed with Chuanxiong Rhizoma for treating thromboembolism diseases. However, the reason for their combination is still being determined. The present study explored the pharmacokinetics interactions of warfarin, Chuanxiong Rhizoma, and gut microbiota in the ra...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849362/ https://www.ncbi.nlm.nih.gov/pubmed/36686675 http://dx.doi.org/10.3389/fphar.2022.1022567 |
_version_ | 1784871943421296640 |
---|---|
author | Li, Haigang Zhou, Yi Liao, Luanfeng Tan, Hongyi Li, Yejun Li, Zibo Zhou, Bilan Bao, Meihua He, Binsheng |
author_facet | Li, Haigang Zhou, Yi Liao, Luanfeng Tan, Hongyi Li, Yejun Li, Zibo Zhou, Bilan Bao, Meihua He, Binsheng |
author_sort | Li, Haigang |
collection | PubMed |
description | Aim: In China, warfarin is usually prescribed with Chuanxiong Rhizoma for treating thromboembolism diseases. However, the reason for their combination is still being determined. The present study explored the pharmacokinetics interactions of warfarin, Chuanxiong Rhizoma, and gut microbiota in the rat model of middle cerebral artery occlusion (MCAO). Methods: A total of 48 rats were randomly divided into six groups: MCAO rats orally administered warfarin (W group), pseudo germ-free MCAO rats orally administered warfarin (W-f group), MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W group), pseudo germ-free MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W-f group), MCAO rats co-administered warfarin and senkyunolide I (S + W group); pseudo germ-free MCAO rats co-administered warfarin and senkyunolide I (S + W-f group). After treatment, all animals’ blood and stool samples were collected at different time points. The stool samples were used for 16S rRNA sequencing analysis. Ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) method was established to quantify warfarin, internal standards, and the main bioactive components of Chuanxiong in blood samples. The main pharmacokinetics parameters of warfarin were calculated by DAS 2.1.1 software. Results: The relative abundance of Allobaculum and Dubosiella in the pseudo germ-free groups (W-f, C + W-f, S + W-f) was lower than that in the other three groups (W, C + W, S + W). The relative abundance of Lactobacillus in the W-f group was higher than that of the W group, while the relative abundance of Akkermansia decreased. The relative abundance of Ruminococcaceae_UCG-014 and Ruminococcaceae_NK4A214_group in the S + W-f group was lower than in the S + W group. Compared to the W group, the AUC(0-t) and C(max) of warfarin in the W-f group increased significantly to 51.26% and 34.58%, respectively. The AUC(0-t) and C(max) in the C + W group promoted 71.20% and 65.75% more than the W group. Compared to the W group, the AUC(0-t) and C(max) increased to 64.98% and 64.39% in the S + W group. Conclusion: Chuanxiong Rhizoma and senkyunolide I (the most abundant metabolites of Chuanxiong Rhizoma aqueous extract) might affect the pharmacokinetics features of warfarin in MCAO rats through, at least partly, gut microbiota. |
format | Online Article Text |
id | pubmed-9849362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98493622023-01-20 Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats Li, Haigang Zhou, Yi Liao, Luanfeng Tan, Hongyi Li, Yejun Li, Zibo Zhou, Bilan Bao, Meihua He, Binsheng Front Pharmacol Pharmacology Aim: In China, warfarin is usually prescribed with Chuanxiong Rhizoma for treating thromboembolism diseases. However, the reason for their combination is still being determined. The present study explored the pharmacokinetics interactions of warfarin, Chuanxiong Rhizoma, and gut microbiota in the rat model of middle cerebral artery occlusion (MCAO). Methods: A total of 48 rats were randomly divided into six groups: MCAO rats orally administered warfarin (W group), pseudo germ-free MCAO rats orally administered warfarin (W-f group), MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W group), pseudo germ-free MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W-f group), MCAO rats co-administered warfarin and senkyunolide I (S + W group); pseudo germ-free MCAO rats co-administered warfarin and senkyunolide I (S + W-f group). After treatment, all animals’ blood and stool samples were collected at different time points. The stool samples were used for 16S rRNA sequencing analysis. Ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) method was established to quantify warfarin, internal standards, and the main bioactive components of Chuanxiong in blood samples. The main pharmacokinetics parameters of warfarin were calculated by DAS 2.1.1 software. Results: The relative abundance of Allobaculum and Dubosiella in the pseudo germ-free groups (W-f, C + W-f, S + W-f) was lower than that in the other three groups (W, C + W, S + W). The relative abundance of Lactobacillus in the W-f group was higher than that of the W group, while the relative abundance of Akkermansia decreased. The relative abundance of Ruminococcaceae_UCG-014 and Ruminococcaceae_NK4A214_group in the S + W-f group was lower than in the S + W group. Compared to the W group, the AUC(0-t) and C(max) of warfarin in the W-f group increased significantly to 51.26% and 34.58%, respectively. The AUC(0-t) and C(max) in the C + W group promoted 71.20% and 65.75% more than the W group. Compared to the W group, the AUC(0-t) and C(max) increased to 64.98% and 64.39% in the S + W group. Conclusion: Chuanxiong Rhizoma and senkyunolide I (the most abundant metabolites of Chuanxiong Rhizoma aqueous extract) might affect the pharmacokinetics features of warfarin in MCAO rats through, at least partly, gut microbiota. Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9849362/ /pubmed/36686675 http://dx.doi.org/10.3389/fphar.2022.1022567 Text en Copyright © 2023 Li, Zhou, Liao, Tan, Li, Li, Zhou, Bao and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Haigang Zhou, Yi Liao, Luanfeng Tan, Hongyi Li, Yejun Li, Zibo Zhou, Bilan Bao, Meihua He, Binsheng Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title | Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title_full | Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title_fullStr | Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title_full_unstemmed | Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title_short | Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
title_sort | pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849362/ https://www.ncbi.nlm.nih.gov/pubmed/36686675 http://dx.doi.org/10.3389/fphar.2022.1022567 |
work_keys_str_mv | AT lihaigang pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT zhouyi pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT liaoluanfeng pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT tanhongyi pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT liyejun pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT lizibo pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT zhoubilan pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT baomeihua pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats AT hebinsheng pharmacokineticseffectsofchuanxiongrhizomaonwarfarininpseudogermfreerats |